GratXray to Present senoa at DeepTech Investor Summit 2026

GratXray AG will participate in the DeepTech Investor Summit 2026 on January 26-27 at ETH Zurich. The event brings together leading venture capitalists, corporate investors, and family offices with over 100 cutting-edge deep tech spin-offs from the ETH domain.

As a PSI and ETH Zurich spin-off, GratXray will present senoa, its revolutionary pain-free 3D breast imaging system that combines diagnostic capabilities with mammography screening and stereotactic biopsy in a single device.

“This summit provides an ideal platform to connect with investors who understand the transformative potential of deep tech innovation in healthcare,” said Martin Stauber, CEO and Co-Founder of GratXray AG. “As we advance senoa’s development and market introduction, engaging with these investors is essential to our growth strategy.”

https://www.b2match.com/e/deeptech-investor-summit-2026